{"id":"https://openalex.org/W7119476138","doi":"https://doi.org/10.3389/fneph.2025.1744454","title":"Progression of immunoglobulin A nephropathy (IgAN) in a Hispanic/Latinx population in the United States","display_name":"Progression of immunoglobulin A nephropathy (IgAN) in a Hispanic/Latinx population in the United States","publication_year":2026,"publication_date":"2026-01-09","ids":{"openalex":"https://openalex.org/W7119476138","doi":"https://doi.org/10.3389/fneph.2025.1744454","pmid":"https://pubmed.ncbi.nlm.nih.gov/41584848"},"language":"en","primary_location":{"id":"doi:10.3389/fneph.2025.1744454","doi":"https://doi.org/10.3389/fneph.2025.1744454","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fneph.2025.1744454","pdf_url":"https://public-pages-files-2025.frontiersin.org/journals/nephrology/articles/10.3389/fneph.2025.1744454/pdf","source":{"id":"https://openalex.org/S4210215820","display_name":"Frontiers in Nephrology","issn_l":"2813-0626","issn":["2813-0626"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Nephrology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://public-pages-files-2025.frontiersin.org/journals/nephrology/articles/10.3389/fneph.2025.1744454/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086117406","display_name":"John J. Sim","orcid":"https://orcid.org/0000-0001-9456-8243","observed_orcids":["https://orcid.org/0000-0001-9456-8243"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I4210096972","display_name":"Los Angeles Medical Center","ror":"https://ror.org/00spys463","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4210096972"]},{"id":"https://openalex.org/I4405260683","display_name":"Kaiser Permanente Bernard J. Tyson School of Medicine","ror":"https://ror.org/0445kkj20","country_code":"US","type":"education","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4405260683"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John J. Sim","raw_affiliation_strings":["Department of Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA,\u00a0United States","Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA,\u00a0United States","Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA,\u00a0United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA,\u00a0United States","institution_ids":["https://openalex.org/I4405260683"]},{"raw_affiliation_string":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA,\u00a0United States","institution_ids":["https://openalex.org/I1343052199"]},{"raw_affiliation_string":"Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA,\u00a0United States","institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I4210096972"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004116670","display_name":"Nancy T. Cannizzaro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy T. Cannizzaro","raw_affiliation_strings":["Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA,\u00a0United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA,\u00a0United States","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5138121833","display_name":"Qiaoling Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qiaoling Chen","raw_affiliation_strings":["Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA,\u00a0United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA,\u00a0United States","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057887317","display_name":"Sasikiran Nunna","orcid":"https://orcid.org/0000-0002-8006-7306","observed_orcids":["https://orcid.org/0000-0002-8006-7306"]},"institutions":[{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sasikiran Nunna","raw_affiliation_strings":["Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD,\u00a0United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD,\u00a0United States","institution_ids":["https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112473765","display_name":"Mohit Mathur","orcid":"https://orcid.org/0000-0001-8300-8902","observed_orcids":["https://orcid.org/0000-0001-8300-8902"]},"institutions":[{"id":"https://openalex.org/I4210110476","display_name":"Visterra (United States)","ror":"https://ror.org/01ph20k51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210110476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohit Mathur","raw_affiliation_strings":["Visterra, Inc., Waltham, MA,\u00a0United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Visterra, Inc., Waltham, MA,\u00a0United States","institution_ids":["https://openalex.org/I4210110476"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083736654","display_name":"Cibele S. Pinto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cibele Pinto","raw_affiliation_strings":["Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD,\u00a0United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD,\u00a0United States","institution_ids":["https://openalex.org/I4405268153"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5086117406"],"corresponding_institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I4210096972","https://openalex.org/I4405260683"],"apc_list":{"value":1950,"currency":"CHF","value_usd":2353},"apc_paid":{"value":1950,"currency":"CHF","value_usd":2353},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0125577,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":null,"first_page":"1744454","last_page":"1744454"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immunoglobulin-a-nephropathy","display_name":"immunoglobulin A nephropathy","score":0.9419999718666077},{"id":"https://openalex.org/keywords/hispanic-patients","display_name":"Hispanic patients","score":0.8410000205039978},{"id":"https://openalex.org/keywords/chronic-kidney-disease-progression","display_name":"chronic kidney disease progression","score":0.7870000004768372},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate-decline","display_name":"estimated glomerular filtration rate decline","score":0.9129999876022339},{"id":"https://openalex.org/keywords/kidney-failure","display_name":"renal failure","score":0.9700000286102295},{"id":"https://openalex.org/keywords/racial-and-ethnic-disparities","display_name":"racial and ethnic disparities","score":0.7459999918937683},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.6240000128746033},{"id":"https://openalex.org/keywords/kidney-biopsy","display_name":"renal biopsy","score":0.41999998688697815},{"id":"https://openalex.org/keywords/immunosuppressive-therapy","display_name":"immunosuppressive therapy","score":0.7400000095367432},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.7609999775886536},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9980000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7930999994277954},{"id":"https://openalex.org/C2781184683","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Nephropathy","level":3,"score":0.573199987411499},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5713000297546387},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5037000179290771},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5026000142097473},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.4796000123023987},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.4668999910354614},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.44780001044273376},{"id":"https://openalex.org/C14036430","wikidata":"https://www.wikidata.org/wiki/Q3736076","display_name":"Function (biology)","level":2,"score":0.3433000147342682},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32249999046325684},{"id":"https://openalex.org/C2780368995","wikidata":"https://www.wikidata.org/wiki/Q605006","display_name":"Glomerulonephritis","level":3,"score":0.3050999939441681},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.27059999108314514},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.26989999413490295},{"id":"https://openalex.org/C2780648854","wikidata":"https://www.wikidata.org/wiki/Q2745824","display_name":"Immunopathology","level":2,"score":0.26989999413490295},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.26409998536109924},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.25380000472068787}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.3389/fneph.2025.1744454","doi":"https://doi.org/10.3389/fneph.2025.1744454","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fneph.2025.1744454","pdf_url":"https://public-pages-files-2025.frontiersin.org/journals/nephrology/articles/10.3389/fneph.2025.1744454/pdf","source":{"id":"https://openalex.org/S4210215820","display_name":"Frontiers in Nephrology","issn_l":"2813-0626","issn":["2813-0626"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Nephrology","raw_type":"journal-article"},{"id":"pmid:41584848","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41584848","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in nephrology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12827094","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12827094/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Front Nephrol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.3389/fneph.2025.1744454","doi":"https://doi.org/10.3389/fneph.2025.1744454","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fneph.2025.1744454","pdf_url":"https://public-pages-files-2025.frontiersin.org/journals/nephrology/articles/10.3389/fneph.2025.1744454/pdf","source":{"id":"https://openalex.org/S4210215820","display_name":"Frontiers in Nephrology","issn_l":"2813-0626","issn":["2813-0626"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Nephrology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.6356948018074036,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320324177","display_name":"Otsuka Pharmaceutical","ror":"https://ror.org/013k5y296"},{"id":"https://openalex.org/F4320333791","display_name":"Otsuka Pharmaceutical Development and Commercialization","ror":"https://ror.org/001nxvg84"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7119476138.pdf","grobid_xml":"https://content.openalex.org/works/W7119476138.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1980040599","https://openalex.org/W1982745873","https://openalex.org/W1995850259","https://openalex.org/W2062155289","https://openalex.org/W2064542290","https://openalex.org/W2138161657","https://openalex.org/W2162337442","https://openalex.org/W2796480735","https://openalex.org/W3201595862","https://openalex.org/W4235787011","https://openalex.org/W4365457345","https://openalex.org/W4378211493","https://openalex.org/W4391847838","https://openalex.org/W4404039235","https://openalex.org/W4410019290","https://openalex.org/W4414335273"],"related_works":[],"abstract_inverted_index":{"Background":[0],"Immunoglobulin":[1],"A":[2],"nephropathy":[3],"(IgAN)":[4],"is":[5],"a":[6,61,76,146,156,168,233,242],"leading":[7],"cause":[8],"of":[9,35,81,119,131,149,159,173,238,247],"chronic":[10],"kidney":[11,36,49,112,133,152,223,257,262],"disease":[12,21],"(CKD)":[13],"worldwide.":[14],"While":[15],"racial":[16],"and":[17,52,66,128,145,167,187,207,241,260,272],"ethnic":[18],"differences":[19],"in":[20,54,105,275],"progression":[22,53,150],"are":[23],"well":[24],"documented,":[25],"the":[26,48,89,106,115,129,267],"Hispanic/Latinx":[27,55,83,140,251],"populations":[28],"remain":[29],"understudied":[30],"despite":[31],"their":[32],"elevated":[33],"risk":[34,148],"failure":[37],"among":[38],"other":[39,70],"CKD":[40,144],"populations.":[41],"Objective":[42],"This":[43],"study":[44,80,116],"aimed":[45],"to":[46,67,69,102,151,236],"evaluate":[47],"function":[50,258],"decline":[51,104,127,197,211,259],"patients":[56,141,252],"with":[57,85,232,253],"biopsy-proven":[58,86],"IgAN":[59,87,254],"within":[60],"large,":[62],"integrated":[63],"healthcare":[64],"system":[65],"contextualize":[68],"racial/ethnic":[71],"groups.":[72],"Methods":[73],"We":[74],"conducted":[75],"retrospective":[77],"case":[78],"series":[79],"259":[82],"adults":[84],"from":[88,100],"Kaiser":[90],"Permanente":[91],"Southern":[92],"California":[93],"(KPSC)":[94],"health":[95],"system.":[96],"Patients":[97],"were":[98,135],"followed":[99],"biopsy":[101],"\u226550%":[103],"estimated":[107],"glomerular":[108],"filtration":[109],"rate":[110],"(eGFR),":[111],"failure,":[113,153],"mortality,":[114],"end":[117],"date":[118],"November":[120],"30,":[121],"2022,":[122],"or":[123],"disenrollment.":[124],"Annualized":[125],"eGFR":[126,158,196],"incidence":[130],"composite":[132,222],"outcomes":[134],"assessed.":[136],"Results":[137],"At":[138],"diagnosis,":[139],"had":[142],"significant":[143],"high":[147],"indicated":[154],"by":[155],"median":[157,169,234,243],"56":[160],"ml":[161,200,213],"min":[162,201,214],"\u22121":[163,202,215],"1.73":[164,203,216],"m":[165,204,217],"\u22122":[166,205,218],"urine":[170],"protein/creatinine":[171],"ratio":[172],"1.8":[174],"g/g.":[175],"Common":[176],"treatments":[177],"included":[178],"immunosuppressive":[179],"agents":[180],"(41%),":[181],"angiotensin-converting":[182],"enzyme":[183],"(ACE)":[184],"inhibitors":[185],"(48%),":[186],"angiotensin":[188],"receptor":[189],"blockers":[190],"(ARBs;":[191],"20%).":[192],"The":[193,221],"mean":[194],"annual":[195],"was":[198],"\u22124.5":[199],",":[206],"30.9%":[208],"experienced":[209],"rapid":[210,256],"(>5":[212],"per":[219,229],"year).":[220],"outcome":[224],"occurred":[225],"at":[226,245],"73.3":[227],"events":[228],"1,000":[230],"patient-years,":[231],"time":[235],"event":[237,246],"2.8":[239],"years":[240],"age":[244],"46":[248],"years.":[249],"Conclusion":[250],"demonstrate":[255],"early-onset":[261],"failure.":[263],"These":[264],"findings":[265],"underscore":[266],"need":[268],"for":[269],"earlier":[270],"detection":[271],"targeted":[273],"management":[274],"this":[276],"underserved":[277],"group.":[278]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2026-01-09T00:00:00"}